Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigger Point Injection and Myofascial Release in Cervicogenic Headache
NCT07910877Not yet recruiting
- Sponsor
- Konya Beyhekim Training and Research Hospital
- Start
- Nov 2026
- Primary completion
- Nov 2027
01
Overview
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in cervicogenic headache (CGH) (4 arms), sponsored by Konya Beyhekim Training and Research Hospital. Primary endpoint: Visual Analog Scale for Pain Intensity at 8 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
cervicogenic headache (CGH)
Beyond the preview
Go deeper on NCT07910877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910877.